FIP makes it a priority to publish the latest developments in pharmacy practice, pharmaceutical sciences, related global news and prominent events. Our multi-media approach to keeping members, partners and peers informed of what is and will be affecting their area of practice or science is key to keeping information flowing through the FIP network.
- Joint Statement of Policy by FIP and the Global Self-Care Federation on Responsible and Effective Self-care
The objective of this statement is to describe the united role and intention of the pharmacy profession and industry in delivering solutions to people to facilitate self-care and in engaging with stakeholders including governments to further develop self-care as a core pillar of sustainable healthcare systems.
- The role of pharmacists in non-communicable diseases
This FIP statement of policy renews the commitment of the profession to the optimal prevention, detection and care of patients living with NCDs.
- Pharmacists supporting women and responsible use of medicines – Empowering informal carers
This policy statement outlines recommendation on how pharmacists, and other stakeholders can support women as informal carers, and the responsible use of medicines.
- Pharmacists’ authority in pharmaceutical product selection: Therapeutic interchange and substitution
The purpose of this document is to provide a set of recommendations on therapeutic interchange and substitution of pharmaceutical products, including with biosimilars.
- The role of pharmacists in reducing harm associated with drugs of abuse
This statement calls on governments to work more with pharmacists on providing harm reduction services and fully involve them in the development of any policies regarding medical or recreational cannabis
- Pharmacy: Gateway to care (2017, Seoul)
This policy statement outlines the importance of the full involvement of pharmacists in self care and replaces FIP’s 1996 statement “Self care including self medication — the professional role of the pharmacist”. It calls for pharmacists to be fully incorporated into health systems both for the prevention and management of illness, and for them to be properly remunerated for delivery of their self-care services. The new statement also makes a number of recommendations for pharmacy organisations and pharmacists.
- Role of the pharmacist in disaster management (2017, Seoul)
This statement makes clear pharmacists’ ethical duty to accept responsibility, as health care professionals, for providing aid to others in disaster situations, and for having plans in place to respond appropriately in the event of a natural or man-made disaster and to limit its impact.
- Strategic development of medicines information for the benefit of patients and users of medicines (Seoul, 2017)
This statement is an update to the federation’s 2008 statement “Medicines information for patients”. In particular, it highlights the importance of the strategic development of medicines information, and describes short-, medium- and long-term outcomes of this approach.
- Control of Antimicrobial Resistance (AMR) (Seoul, 2017)
This policy made a number of new recommendations to governments and pharmacists, reflecting developments FIP’s last statement on this topic in 2008, which include the declaration of antimicrobial resistance as a public health emergency and new global policies and commitments against the escalating threat to the control of infectious diseases.
- Environmentally sustainable pharmacy practice: Green pharmacy (2016, Buenos Aires)
This policy statements makes clear that pharmacists and pharmaceutical scientists must take responsibility for mitigating the environmental consequences of medicines, and this responsibility encompasses the entire course of medicines use, from manufacture and distribution to prescribing and dispensing, and to disposal and reduction of the discharge of metabolites of medicines into the environment. It sets out a number of recommended actions for FIP member organisations (national professional associations of pharmacy and pharmaceutical sciences), schools of pharmacy, individual pharmacists and governments. It also highlights the contribution non-adherence makes to medicines waste.
- The Effective Utilization of Pharmacists in Improving Maternal, Newborn and Child Health (MNCH) (2013, Dublin)
This policy document focuses on the effective contribution of pharmacists in improving maternal, newborn and child health.
- FIP Centennial Declaration (2012, Amsterdam)
- Collaborative Pharmacy Practice (2010, Lisbon)
- Control of Antimicrobial Medicines Resistance (2008, Basel)
- Medicines Information for Patients (2008, Basel)
- Quality of Medicines used for Children (2008, Basel)
- The Role Of The Pharmacist In Pharmacovigilance (2006, Brazil)
- The Role Of The Pharmacist In the Prevention And Treatment Of Chronic Disease (2006, Brazil)
- Improving Access to Medicines in Developing Countries (2005, Cairo)
- Point of Care Testing in Pharmacies (2004, New Orleans)
- Counterfeit Medicines (2003, Sydney)
- The Role of the Pharmacist in Promoting a Future Free of Tobacco (2003, Sydney)
- Good Practice in Donations of Medicines (1997, Vancouver)
- The Pharmacist's Authority in Product Selection ― Therapeutic Interchange and Generic Substitution (1997, Vancouver)
FIP members To access video recordings of previous webinars, please go to the FIP Library